|
Dose finding study of the intratumoral administration of the oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG). |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - IST GmbH |
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - BrainLab; Celldex |
Patents, Royalties, Other Intellectual Property - Annias, Intellectual Property |
|
|
Honoraria - Genentech/Roche; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Pfizer |
Speakers' Bureau - Genentech/Roche; Pfizer |
Research Funding - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Pfizer |
|
|
Consulting or Advisory Role - Agios; Novocure |
Research Funding - Agios; BioMimetix; Eisai; Genentech; Merck; VBL Therapeutics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - IST GmbH |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Arno Therapeutics; IST GmbH; Tactical Therapeutics |
Honoraria - Genentech/Roche |
Consulting or Advisory Role - Genentech/Roche |
Speakers' Bureau - Genentech/Roche |
Patents, Royalties, Other Intellectual Property - Letters of Patent for Oncolytic Poliovirus for Human Tumors |
|
|
Stock and Other Ownership Interests - IST GmbH |
Patents, Royalties, Other Intellectual Property - Letters of Patent for Oncolytic Poliovirus for Human Tumors |
|
|
Stock and Other Ownership Interests - IST GmbH |
Patents, Royalties, Other Intellectual Property - Letters of Patent for Oncolytic Poliovirus for Human Tumors |